Creative Medical Technology Holdings (CELZ) Enterprise Value (2017 - 2025)
Creative Medical Technology Holdings (CELZ) has disclosed Enterprise Value for 16 consecutive years, with -$5.4 million as the latest value for Q3 2025.
- On a quarterly basis, Enterprise Value rose 14.14% to -$5.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$5.4 million, a 14.14% increase, with the full-year FY2024 number at -$5.9 million, down 71.35% from a year prior.
- Enterprise Value was -$5.4 million for Q3 2025 at Creative Medical Technology Holdings, up from -$6.5 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$158588.0 in Q2 2021 to a low of -$22.9 million in Q2 2022.
- A 5-year average of -$9.4 million and a median of -$7.7 million in 2025 define the central range for Enterprise Value.
- Peak YoY movement for Enterprise Value: crashed 14317.02% in 2022, then skyrocketed 81.16% in 2023.
- Creative Medical Technology Holdings' Enterprise Value stood at -$10.7 million in 2021, then plummeted by 71.57% to -$18.4 million in 2022, then surged by 81.16% to -$3.5 million in 2023, then plummeted by 71.35% to -$5.9 million in 2024, then rose by 9.51% to -$5.4 million in 2025.
- Per Business Quant, the three most recent readings for CELZ's Enterprise Value are -$5.4 million (Q3 2025), -$6.5 million (Q2 2025), and -$7.7 million (Q1 2025).